Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 928-779-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001-01-22 to 2001-03-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Deviations:
- yes
- Remarks:
- A limit study was performed and not a full study with two sexes and three dose levels as is recommended by the authorities, if the test substance is genotoxic
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 2000
- Deviations:
- yes
- Remarks:
- A limit study was performed and not a full study with two sexes and three dose levels as is recommended by the authorities, if the test substance is genotoxic
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 1-(3,5-dihydroxyphenyl)-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethan-1-one hydrobromide
- EC Number:
- 928-779-0
- Cas Number:
- 1178555-23-1
- Molecular formula:
- C18-H21-N-O4 x HBr
- IUPAC Name:
- 1-(3,5-dihydroxyphenyl)-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethan-1-one hydrobromide
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: No details on the source of the test material were provided. Batch number: 375.
- Expiration date of the lot/batch: 01 March 2001 (allocated by testing facility, 1 year after reciept of the test substance).
- Purity test date:No details reported.
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature in the dark.
- Stability under test conditions:Stable
- Solubility and stability of the test substance in the solvent/vehicle: The stability of the test substance in the vehicle was not indicated.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: No details reported.
- Preliminary purification step (if any): No details reported.
- Final dilution of a dissolved solid, stock liquid or gel: No details reported.
- Final preparation of a solid: No details reported.
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Remarks:
- BR (SPF)
- Details on species / strain selection:
- Recommended test system in international guidelines.
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: 6 - 8 weeks old
- Weight at study initiation: 30.6 +- 1.5 to 31.8 +- 1.9 g
- Assigned to test groups randomly: yes
- Housing: Group housing of 5 animals per sex per cage in labeled polycarbonate cages containing purified sawdust
- Diet (e.g. ad libitum): free access, (Altromin (code VRF 1), Lage, Germany).
- Water (e.g. ad libitum): free access, tap water
- Acclimation period: at least 5 days before start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +- 3 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours artificial light, 12 hours dark
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil (OPG, Utrecht, The Netherlands) for the test substance and physiological saline (Fresenius B.V., ´s-Hertogenbosch, The Netherlands)
- Concentration of test material in vehicle: 150 mg/ml suspension - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was suspended in corn oil (OPG, Utrecht, The Netherlands). The test item concentrations were blended and treated with ultra-sonic waves to obtain a homogeneous suspension. The test item concentrations were dosed within 4 hours after preparation - Duration of treatment / exposure:
- The mice received an intraperitoneal injection of a maximum tolerated dose. The route of administration was chosen to maximize the chance of the test article reaching the target tissue. The dosing volume was 10 ml/kg body weight. The route and frequency of administration and the volume administered of the negative and the positive control was the same as those of the test article.
- Frequency of treatment:
- single (dosing volume 10 ml/kg bw)
Doses / concentrations
- Dose / conc.:
- 150 mg/kg bw (total dose)
- Remarks:
- nominal conc.
- No. of animals per sex per dose:
- 2 male mice in each treatment group were used in the dose range finding study
5 male mice per sampling time in each treatment group were used in the micronucleus test. - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide (CP; CAS 50-18-0; Endoxan, Asta-Werke, F.R.G.)
Examinations
- Tissues and cell types examined:
- micronucleated polychromatic erythrocytes (bone marrow)
- Details of tissue and slide preparation:
- The animals were sacrificed by cervical dislocation 24 or 48 h after dosing of the test substance, 24 h after dosing of the vehicle and 48 h after dosing of the positive control. Both femurs were removed and freed of blood and muscles. Both ends of the bone were shortened until a small opening to the marrow canal became visible. The bone was flushed with approximately 2 ml of foetal calf serum. The cell suspension was collected and centrifuged at 1000 rpm (approx. 100 g) for 5 min.
The supernatant was removed with a Pasteur pipette. A drop of serum was left on the pellet. The cells in the sediment were carefully mixed with the serum by aspiration with the remaining serum. A drop of the cell suspension was placed on the end of a slide which was previously cleaned (24 h immersed in a 1:1 mixture of 96% (v/v) ethanol/ether and cleaned with a tissue) and marked (with the study identification number and the animal ID number). The drop was spread by moving a clean slide with round-whetted sides at an angle of approx. 45° over the slide with the drop of bone marrow suspension. The preparations were air-dried, fixed for 5 min in 100% methanol and air-dried overnight. Two slides were prepared per animal.
Staining of the bone marrow smears:
The slides were automatically stained using the 'Wright-stain-procedure' in an 'Ames' HEMA-tek slide stainer (Miles, Bayer Nederland B. V.). The dry slides were dipped in xylene before they were embedded in MicroMount and mounted with a coverslip.
Analysis of the bone marrow smears for micronuclei:
All slides were randomly coded before examination. An adhesive label with NOTOX study identification number and code was stuck over the marked slide. At first the slides were screened at a magnification of 100* for regions of suitable technical quality, i. e. where the cells were well spread, undamaged and well stained.. Slides were scored at a magnification of 1000*. The number of micronucleated polychromatic erythrocytes was determined by counting and differentiating the first 1000 erythrocytes at the same time. Micronuclei were only counted in poly chromatic erythrocytes. Averages and standard deviations were calculated. - Evaluation criteria:
- Equivocal results should be clarified by further testing using modification of experimental conditions.
A test substance is considered positive in the micronucleus test if:
- It induced a biologically as well a statistically significant increase in the frequency of micronucleated polychromatic erythrocytes.
A test substance is considered negative in the micronucleus test if:
- None of the tested concentrations or sampling times showed a statistically significant (P < 0.05) increase in the incidence of micronucleated polychromatic erythrocytes. - Statistics:
- The Wilcoxon Rank Sum Test, two-sided test at P< 0.05 and historical control data range were used to verify the results, taking into account the characteristics of the micronucleus assay. A probability of P < 5% (cells with micronuclei in any dose group) was considered statistically significant.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- substance caused clinical signs of toxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY 1
- Dose range: 2000, 1000, 250 mg/kg bw
- Number of animals: 6 (2 males per group)
- Clinical signs of toxicity in test animals: refer to table 1
RESULTS OF Micronucleus Test 1
- Dose: 250 mg/kg bw
- Number of animals: 5 males per group, 3 additional animals to correct for possible deaths
- Clinical signs of toxicity in test animals: during the first hour after dosing all animals were lethargic. Within 20 hours after dosing ten animals died, two animals were only lethargic and one animal was lethargic, had a rough coat and a hunched posture
- Rationale for exposure: based on the results of the range-finding study 1
RESULTS OF RANGE-FINDING STUDY 2
- Dose range: 150 mg/kg
- Number of animals: 2 males
- Clinical signs of toxicity in test animals: within 2 hours after dosing both animals showed ataxia and one animal showed also tremors and salivation. Within 20 hours after dosing both animals showed no abnormalities.
- Rationale for exposure: since the dose level of 250 mg/kg bw was too toxic for the mice, this additional dose range finding study was performed.
RESULTS OF Micronucleus Test 2 (main test)
- Dose 150 mg/kg bw
- Number of animals: 5 males per group
- Clinical signs of toxicity in test animals: within two hours after dosing three animals showed ataxia. Within 20 hours after dosing one animal showed a hunched posture and one animal had a rough coat and a hunched posture. Within 44 hours after dosing one animal still showed a hunched posture; the other animals showed no abnormalities.
- Ratio of PCE/NCE (for Micronucleus assay): no decrease in the ratio of polychromatic erythrocytes (refer to Table 3)
- Statistical evaluation: Wilcoxon Rank Sum Test, P <= 0.01
Any other information on results incl. tables
Dose range finding study 1
In the dose range finding study 6 animals (2 males per group) were dosed intraperitoneally with 2000, 1000 and 250 mg/kg body weight (groups A, B and C respectively). The results of this dose range finding study are presented in Table 1.
Table 1 Mortality and systemic toxic signs after treatment of the test item in the dose range finding study
Group | Sex | Dose mg/kg | Systemic toxic signs* day | day 2 | |||
15 min | 30 min | 1 hr | 1.5 -2 hr | ||||
A | Male | 2000 | CE | A | |||
A | Male | 2000 | CE | A | |||
B | Male | 1000 | B | A | |||
B | Male | 1000 | B | CE; A | |||
C | Male | 250 | CF | B | B | ||
C | Male | 250 | CF | B | A |
*) A=died; B=showed no abnormalities; C=ataxia; E=tremor; F=lethargy
Micronucleus Test 2 (main test):
Micronucleated polychromatic erythrocytes
The mean number of micronucleated polychromatic erythrocytes per group and the mean ratio of polychromatic to normochromatic erythrocytes are presented in Table 2. The indivudual data are described in Table 3. The mean number of micronucleated polychromatic erythrocytes scored in the test item treated groups were compared with the corresponding solvent control group.
No biologically significant increase in the frequency of micronucleated polychromatic erythroytes was observed in the polychromatic erythrocytes of the bone marrow of the test item treated animals compared to the vehicle treated animals.
The incidence of micronucleated polychromatic erythrocytes in the bone marrow of all negative control animals was within the historical solvent control data range.
Cyclophosphamide, the positive control substance, induced a statistically significant increase in the number of micronucleated polychromatic erythrocytes. Hence, the acceptability criteria of the test were met.
Table 2: Mean number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes and ratio of polychromatic/norchromatic erythrocytes
Group | Treatment | Dose (mg/kg bw) | Sampling time (hours) | Number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes (mean +- S.D.)* | Ratio polychromatic erythrocytes (mean +- S.D.)* |
A | vehicle | 0 | 24 | 0.2 +- 0.4 | 1.17 +- 0.17 |
B | Test item | 150 | 24 | 1.4 +- 1.3 | 0.89 +- 0.11 |
C | Test item | 150 | 48 | 1.0 +- 1.4 | 1.05 +- 0.03 |
D | CP | 50 | 48 | 23.8 +- 16.9** | 0.42 +- 0.09 |
Vehicle = corn oil
CP = Cyclophoshamide
* Five animals per treatment group
** Significantly different from corresponding control group (Wilcoxon Rank Sum Test, P <= 0.01)
Table 3: Individual data
Group | Animal number | Number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes | Ratio polychromatic erythrocytes |
A | 1 | 0 | 1.29 |
A | 2 | 0 | 1.26 |
A | 3 | 1 | 1.34 |
A | 4 | 0 | 0.97 |
A | 5 | 0 | 1.00 |
B | 6 | 2 | 1.00 |
B | 7 | 0 | 0.86 |
B | 8 | 3 | 0.94 |
B | 9 | 2 | 0.71 |
B | 10 | 0 | 0.94 |
C | 11 | 0 | 1.05 |
C | 12 | 3 | 1.02 |
C | 13 | 2 | 1.04 |
C | 14 | 0 | 1.04 |
C | 15 | 0 | 1.11 |
D | 16 | 16 | 0.56 |
D | 17 | 27 | 0.38 |
D | 18 | 12 | 0.43 |
D | 19 | 12 | 0.31 |
D | 20 | 52 | 0.40 |
A: intraperitoneal injection of corn oil
B-C: intraperitoneal injection of the test item
D: intraperitoneal injection of Cyclophosphamide
Applicant's summary and conclusion
- Conclusions:
- The males that were exposed to the test substance showed no decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the vehicle controls, which reflects a lack of toxic effects of the compound on the erythropoesis. It is concluded that the test substance is not mutagenic in the micronucleus test under the experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
